Apr 2, 2025
BIG PHARMA WATCH: PFIZER AVOIDED PAYING BILLIONS IN U.S. TAXES THROUGH “EGREGIOUS TAX GIMMICK”
Big Pharma Giant Used “Round-Tripping” Tax Avoidance Scheme to Attribute U.S. Sales…
© 2025 CSRXP- All Rights Reserved
HOLDING BIG PHARMA ACCOUNTABLE
HOLDING
BIG PHARMA ACCOUNTABLE
CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for egregious pricing and anti-competitive practices that are the root cause of out-of-control drug prices in America.
We believe in market-based reforms to lower drug prices for patients through increased transparency, competition and value.
The BIG PHARMA Playbook
Big Pharma’s business-as-usual playbook relies on egregious pricing practices and rhetoric designed to set and keep drug prices high.
Out-of-Control Price Hikes & Launch Prices
Innovation Rhetoric Disconnected from the Facts
Blame Game Designed to Keep Prices High
Anti-Competitive Tactics & Patent Abuse
CSRxP’s Solutions
Drug prices in the United States are out of control as a direct result of the egregious pricing and anti-competitive practices of brand name pharmaceutical companies. Rising prescription drug prices threaten the affordability of our health care system, the long-term health of our nation and the vitality of our entire economy. Public opinion research finds as many as one-in-three Americans experience financial difficulty, either as a patient themselves or through a family member, affording prescription drugs. CSRxP has developed market-based solutions to restore a functioning market and lower prices for patients by increasing list price transparency, promoting competition and actual innovation and focusing on better value for patients, not better value for pharmaceutical companies.
News & Updates
Mar 18, 2025
CSRXP ANALYSIS FINDS BIG PHARMA’S DIRECT-TO-CONSUMER (DTC) ADVERTISING COSTS U.S. TAXPAYERS BILLIONS OF DOLLARS
Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion in Annual…
Mar 14, 2025
CSRXP APPLAUDS U.S. SENATE REINTRODUCTION OF BIPARTISAN, MARKET-BASED SOLUTIONS TO LOWER DRUG PRICES BY ADDRESSING BIG PHARMA’S PATENT ABUSE
Cracking Down on Anti-Competitive Tactics Like Patent-Thicketing and Product-Hopping…
Mar 12, 2025
They Said It!: Lawmakers And FDA Nominee Highlight Greater Competition As Critical To Lowering Prescription Drug Prices
U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious Patent…
Featured Content
Apr 2, 2025
Fact Sheet: Patent Abuse
Big Pharma has a long history of price-gouging American patients… Read More
Mar 25, 2025
CSRxP Analysis: DTC Report
Direct-to-Consumer (DTC) pharmaceutical advertising spending, tax implications… Read More
Mar 20, 2025
Toolkit: Drug Pricing Overview – 119th Congress
The CSRxP toolkit provides key facts and background on the prescription drug… Read More
Nov 20, 2024
CSRxP: Margin Analysis
Pharmaceutical manufacturers’ average annual net income margin is higher… Read More
Resources
Videos
Watch and learn about Big Pharma’s price-gouging techniques that are the cause of out-of-control drug prices.
Fact Sheets
Get the facts on Big Pharma’s anti-competitive tactics, like price-gouging and patent abuse that keeps drug prices high.
Infographics
Learn about how Big Pharma is driving the Rx drug pricing crisis with our infographics.
Polling
See recent surveys on American voters’ opinions on Big Pharma’s blame game and out-of-control drug pricing.
JOIN THE FIGHT
Join us in telling lawmakers: It’s time to hold Big Pharma accountable and lower Rx drug prices.